Opus Genetics IRD Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.16M-44.2% | $3.87M+25.5% | $3.08M+6.8% | $2.88M-34.1% | $4.37M+1.6% | ||
| $10.58M— | —— | $6.41M— | —— | $7.95M— | ||
| $5.94M+21.6% | $4.89M-1.8% | $4.98M-13.6% | $5.77M-9.1% | $6.35M-13.0% | ||
| $16.52M+7.9% | $15.32M+34.5% | $11.39M-3.4% | $11.79M-17.6% | $14.3M-66.2% | ||
| -$14.36M-25.4% | -$11.45M-37.8% | -$8.31M+6.7% | -$8.91M+10.3% | -$9.93M+73.9% | ||
| -665.9%-370pp | -296.3%-26.4pp | -269.9%+39.1pp | -309%-81.8pp | -227.2%+657pp | ||
| $69K+13.1% | $61K-10.3% | $68K— | $0— | $0— | ||
| $844K+20.1% | $703K+56.2% | $450K-15.7% | $534K+76.8% | $302K-89.3% | ||
| -$65.54M-297% | -$16.52M+5.3% | -$17.45M-135% | -$7.42M+9.4% | -$8.19M+76.7% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$65.54M-297% | -$16.52M+5.3% | -$17.45M-135% | -$7.42M+9.4% | -$8.19M+76.7% | ||
| -3,038.2%-2,611pp | -427.5%+139pp | -566.9%-309pp | -257.5%-70.0pp | -187.5%+629pp | ||
| -$0.75-257% | -$0.21+16.0% | -$0.25-108% | -$0.12+50.0% | -$0.24+81.1% | ||
| -$14.35M-25.4% | -$11.44M-37.9% | -$8.3M+6.7% | -$8.89M+10.3% | -$9.92M+73.9% | ||
| -665.3%-369pp | -296%-26.5pp | -269.5%+39.0pp | -308.5%-81.6pp | -226.9%+657pp | ||
| -$14.36M-25.4% | -$11.45M-37.8% | -$8.31M+6.7% | -$8.91M+10.3% | -$9.93M+73.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Opus Genetics's revenue?
- Opus Genetics (IRD) generated $12.0M in revenue over the trailing twelve months, down 12.2% year over year.
- Is Opus Genetics profitable?
- Opus Genetics is not currently profitable: it reported a net loss of $106.9M over the trailing twelve months, a -892.4% net margin.
- What is Opus Genetics's earnings per share?
- Opus Genetics's diluted EPS over the trailing twelve months is $-1.33.
- Where does Opus Genetics's income statement data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
